Form 4 for SNPS Synopsys
Accepted 2021-12-13 00:00:00 ET · period of report 2021-12-09 · accession 0001199719-21-000115 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-12-13 | 2021-12-09 | SNPS | DE GEUS AART | COB, Co-CEO, Dir | F - Tax | $354.48 | -5,941 | 79.1K | -7% | -$2.11M |
| D | 2021-12-13 | 2021-12-09 | SNPS | DE GEUS AART | COB, Co-CEO, Dir | A - Grant | $0.00 | +8,244 | 83.2K | +11% | $0 |
| D | 2021-12-13 | 2021-12-09 | SNPS | DE GEUS AART | COB, Co-CEO, Dir | M - OptEx | $0.00 | +3,737 | 82.8K | +5% | $0 |
| DM | 2021-12-13 | 2021-12-09 | SNPS | DE GEUS AART | COB, Co-CEO, Dir | A - Grant | $0.00 | +37.7K | 17.8K | New | $0 |
| D | 2021-12-13 | 2021-12-09 | SNPS | DE GEUS AART | COB, Co-CEO, Dir | D - Sale to Iss | $0.00 | -3,737 | 16.8K | -18% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-12-09 | F | D | 1,853 | $354.48 | 80,993 | D | — | — | (F2) These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the performance-based restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. |
| 2 | Common | Common Stock | 2021-12-09 | A | A | 8,244 | $0.00 | 83,197 | D | — | — | (F1) Represents one tranche of a performance-based restricted stock award granted on October 18, 2019 for which a non-GAAP operating margin goal for the fiscal year ended October 30, 2021 was determined by the Compensation Committee to have been achieved on December 9, 2021. All of the stock units subject to this tranche vested on December 9, 2021. |
| 3 | Common | Common Stock | 2021-12-09 | F | D | 4,088 | $354.48 | 79,109 | D | — | — | (F2) These shares were retained by the Company in order to meet the tax withholding obligations of the reporting person in connection with the vesting of an installment of the performance-based restricted stock unit award. The Compensation Committee approved the disposition of shares by the reporting person and the amount retained by the Company was not in excess of the amount of the tax liability. |
| 4 | Common | Common Stock | 2021-12-09 | M | A | 3,737 | $0.00 | 82,846 | D | — | — | |
| 5 | Derivative | Restricted Stock Units | 2021-12-09 | A | A | 14,947 | $0.00 | 20,552 | D | $0.00 · 2021-12-09 to 2024-12-08 | 14,947 Common Stock | |
| 6 | Derivative | Restricted Stock Units | 2021-12-09 | A | A | 4,937 | $0.00 | 4,937 | D | $0.00 · 2022-12-08 to 2025-12-08 | 4,937 Common Stock | (F6) 25% of the units vest on the date shown followed by three equal annual installments. |
| 7 | Derivative | Restricted Stock Units | 2021-12-09 | D | D | 3,737 | $0.00 | 16,815 | D | $0.00 · 2021-12-09 to 2024-12-08 | 3,737 Common Stock | (F6) 25% of the units vest on the date shown followed by three equal annual installments. |
| 8 | Derivative | Non-Qualified Stock Option (right to buy) | 2021-12-09 | A | A | 17,828 | $0.00 | 17,828 | D | $354.48 · 2022-12-09 to 2028-12-09 | 17,828 Common Stock | (F4) 1/4 of the grant becomes exercisable one year after grant date with the remainder becoming exercisable in a series of 12 equal quarterly installments thereafter, subject to continued service through each vesting date. |